Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Die Folgen des Klimwandels haben einen direkten Einfluss auf die Primärversorgung in Deutschland: Hitzeschutz insbesondere bei älteren Patienten, die Zunahme von Infektionen und die Verlängerung der Allergiesesaison spielen medizinisch eine bedeutsame Rolle. Aber auch in der Prävention und der Aufklärung der Patienten kommt den Hausärztinnen und -ärzten eine besondere Rolle zu. Direkt aus der Praxis berichtet im Live-Webinar am 13. Mai von 18 bis 19 Uhr unser Experte Dr. med. Robin Maitra.
Erweiterte Suche
Anmelden
nach oben
Journal of Cancer Survivorship
Erschienen in: Journal of Cancer Survivorship 4/2023

05.12.2022

Subjective cancer-related cognitive impairments and salience network connectivity in breast cancer survivors

verfasst von: Ashley M. Henneghan, Shelli R. Kesler

Erschienen in: Journal of Cancer Survivorship | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Little is known about the neural basis of subjective cancer-related cognitive changes. The purpose of this study was to explore salience network connectivity in relation to subjective executive and memory dysfunction in breast cancer survivors compared to controls.

Methods

A retrospective cross-sectional analysis of neuroimaging, subjective cognitive, clinical, and demographic data in chemotherapy-treated primary breast cancer survivors compared to frequency matched controls was used. Functional connectivity within salience network hubs (anterior cingulate, bilateral insula) was determined using resting state functional MRI. Mann–Whitney U tests were used to evaluate group differences and Spearman’s rho correlations were examined among the behavioral measures and salience network connectivity.

Results

We included 65 breast cancer survivors and 71 controls. Survivors demonstrated greater subjective executive dysfunction and memory complaints (p < .001) and lower salience network connectivity (p < .05) than controls. Executive functioning correlated with bilateral insula and left anterior cingulate connectivity (rho >  − 0.29, p < .05). Distress did not correlate with salience network connectivity.

Conclusion

These findings suggest that salience network connectivity may represent a biomarker of subjective cancer-related cognitive changes.

Implications for Cancer Survivors

Subjective cancer-related cognitive changes are common following treatment and associated with objective changes in brain connectivity
Literatur
1.
Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, Winocur G, De Ruiter MB, Castel H. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019;30(12):1925–40.PubMedCrossRef
2.
Selamat MH, Loh SY, Mackenzie L, Vardy J. Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. PLoS One. 2014;9(9):e108002.PubMedPubMedCentralCrossRef
3.
Porro B, Durand MJ, Petit A, Bertin M, Roquelaure Y. Return to work of breast cancer survivors: toward an integrative and transactional conceptual model. J Cancer Surviv. 2021;16(3):590–603.PubMedPubMedCentralCrossRef
4.
Mayo SJ, Lustberg M, Dhillon HM, Nakamura ZM, Allen DH, Von ah D, Janelsins MC, Chan A, Olson K, Tan CJ, Toh YL, Oh J, Grech L, Cheung YT, Subbiah IM, Petranovic D, D’Olimpio J, Gobbo M, Koeppen S, Loprinzi CL, Pang L, Shinde S, Ntukidem O, Peters KB. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. Support Care Cancer. 2021;29(6):2821–40.PubMedCrossRef
5.
Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv. 2018;12(4):537–59.PubMedCrossRef
6.
Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38(7):926–34.PubMedCrossRef
7.
Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015;65(2):123–38.PubMedCrossRef
8.
Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33–50.PubMedCrossRef
9.
Simo M, Rifa-Ros X, Rodriguez-Fornells A, Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev. 2013;37(8):1311–21.PubMedCrossRef
10.
Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, Dhabhar FS. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013;30(Suppl):S109–16.PubMedCrossRef
11.
Kesler SR. Prevalence of cerebral small-vessel disease in long-term breast cancer survivors exposed to both adjuvant radiotherapy and chemotherapy. Breast Diseases: A Year Book Quarterly. 2015;26(4):353.
12.
Correa DD, Ahles TA. Neurocognitive changes in cancer survivors. Cancer J. 2008;14(6):396–400.PubMedCrossRef
13.
Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12(7):703–8.PubMedCrossRef
14.
Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011;38(3):431–8.PubMedPubMedCentralCrossRef
15.
Vardy J. Cognitive function in breast cancer survivors. Cancer Treat Res. 2009;151:387–419.PubMedCrossRef
16.
Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116(14):3348–56.PubMedCrossRef
17.
Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer. 2005;104(10):2222–33.PubMedCrossRef
18.
McDonald BC, Conroy SK, Smith DJ, West JD, Saykin AJ. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun. 2013;30(Suppl):S117–25.PubMedCrossRef
19.
Kesler SR, Kent JS, O’Hara R. Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol. 2011;68(11):1447–53.PubMedPubMedCentralCrossRef
20.
Askren MK, Jung M, Berman MG, Zhang M, Therrien B, Peltier S, Ossher L, Hayes DF, Reuter-Lorenz PA, Cimprich B. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation. Breast Cancer Res Treat. 2014;147(2):445–55.PubMedPubMedCentralCrossRef
21.
Apple AC, Schroeder MP, Ryals AJ, Wagner LI, Cella D, Shih PA, Reilly J, Penedo FJ, Voss JL, Wang L. Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy. NeuroImage Clin. 2018;20:110–8.PubMedPubMedCentralCrossRef
22.
S.R. Kesler, T. Tang, A.M. Henneghan, M. Wright, M.W. Gaber, O. Palesh, Cross-sectional characterization of local brain network connectivity pre and post breast cancer treatment and distinct association with subjective cognitive and psychological function, Frontiers in neurology 12(1969) (2021).
23.
Kesler SR, Wefel JS, Hosseini SM, Cheung M, Watson CL, Hoeft F. Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc Natl Acad Sci USA. 2013;110(28):11600–5.PubMedPubMedCentralCrossRef
24.
Dumas JA, Makarewicz J, Schaubhut GJ, Devins R, Albert K, Dittus K, Newhouse PA. Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging Behav. 2013;7(4):524–32.PubMedCrossRef
25.
Zeng Y, Cheng ASK, Song T, Sheng X, Zhang Y, Liu X, Chan CCH. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study. BMC Cancer. 2017;17(1):796.PubMedPubMedCentralCrossRef
26.
Chand GB, Wu J, Hajjar I, Qiu D. Interactions of the salience network and its subsystems with the default-mode and the central-executive networks in normal aging and mild cognitive impairment. Brain Connectivity. 2017;7(7):401–12.PubMedPubMedCentralCrossRef
27.
28.
Chong JSX, Ng GJP, Lee SC, Zhou J. Salience network connectivity in the insula is associated with individual differences in interoceptive accuracy. Brain Struct Funct. 2017;222(4):1635–44.PubMedCrossRef
29.
Roth RM, Lance CE, Isquith PK, Fischer AS, Giancola PR. Confirmatory factor analysis of the behavior rating inventory of executive function-adult version in healthy adults and application to attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol. 2013;28(5):425–34.PubMedPubMedCentralCrossRef
30.
Troyer AK, Rich JB. Psychometric Properties of a New Metamemory Questionnaire for Older Adults. J Gerontol B Psychol Sci Soc Sci. 2002;57(1):P19–27.PubMedCrossRef
31.
AAghakhani EK Chan Test Reviews: Bracken BA, Howell K 2004. Clinical Assessment of Depression Odessa, FL: Psychological Assessment Resources. J Psychoeduc Assess. 2007;25(4):416–22. CrossRef
32.
Glover GH, Lai S. Self-navigated spiral fMRI: interleaved versus single-shot. Magn Reson Med. 1998;39(3):361–8.PubMedCrossRef
33.
34.
Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connectivity. 2012;2(3):125–41.PubMedCrossRef
35.
Behzadi Y, Restom K, Liau J, Liu TT. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage. 2007;37(1):90–101.PubMedCrossRef
36.
Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15(1):273–89.PubMedCrossRef
37.
Van der Gucht K, Ahmadoun S, Melis M, de Cloe E, Sleurs C, Radwan A, Blommaert J, Takano K, Vandenbulcke M, Wildiers H, Neven P, Kuppens P, Raes F, Smeets A, Sunaert S, Deprez S. Effects of a mindfulness-based intervention on cancer-related cognitive impairment: results of a randomized controlled functional magnetic resonance imaging pilot study. Cancer. 2020;126(18):4246–55.PubMedCrossRef
38.
R.M. Roth, P.K. Isquith, G. Gioia, Behavioral rating inventory of executive function - adult version, Psychological Assessment Resources, Lutz, FL, 2005.
39.
Friedman NP, Robbins TW. The role of prefrontal cortex in cognitive control and executive function. Neuropsychopharmacol. 2022;47(1):72–89.CrossRef
40.
Menon V, D’Esposito M. The role of PFC networks in cognitive control and executive function. Neuropsychopharmacol. 2022;47(1):90–103.CrossRef
41.
Bernstein LJ, Edelstein K, Sharma A, Alain C. Chemo-brain: an activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies. Neurosci Biobehav Rev. 2021;130:314–25.PubMedCrossRef
42.
Gratton C, Sun H, Petersen SE. Control networks and hubs. Psychophysiol. 2018;55(3):e13032.
43.
Hou J, Song B, Chen ACN, Sun C, Zhou J, Zhu H, Beauchaine TP. Review on neural correlates of emotion regulation and music: implications for emotion dysregulation. Front Psychol. 2017;8:501.PubMedPubMedCentralCrossRef
44.
Conley CC, Bishop BT, Andersen BL. Emotions and emotion regulation in breast cancer survivorship. Healthcare (Basel). 2016;4(3):56.PubMedCrossRef
45.
Arndt J, Das E, Schagen SB, Reid-Arndt SA, Cameron LD, Ahles TA. Broadening the cancer and cognition landscape: the role of self-regulatory challenges. Psychooncol. 2014;23(1):1–8.CrossRef
46.
Flavell JH. Metacognition and cognitive monitoring: a new area of cognitive-developmental inquiry. Am Psychol. 1979;34(10):906–11.CrossRef
47.
Vaccaro AG, Fleming SM. Thinking about thinking: a coordinate-based meta-analysis of neuroimaging studies of metacognitive judgements. Brain Neurosci Adv. 2018;2:2398212818810591.PubMedPubMedCentralCrossRef
48.
Perrier J, Joue G, Desgranges B, Allouache D, Levy C, Noal S, Dayan J, Eustache F, Joly F, Viard A, Giffard B. Self-referential processes and resting-state connectivity in breast cancer patients before and 1 year after chemotherapy. Eur J Neurosci. 2022;55(2):624–36.PubMedCrossRef
49.
Sha Z, Wager TD, Mechelli A, He Y. Common dysfunction of large-scale neurocognitive networks across psychiatric disorders. Biol Psychiatry. 2019;85(5):379–88.PubMedCrossRef
50.
Kesler SR, Wayfull JS, Hosseini SM, Cheung M, Watson CL, Hoeft F. Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc Natl Acad Sci USA. 2013;110(28):11600–5. PubMedPubMedCentralCrossRef
51.
Sharma N, Murari G, Vandermorris S, Verhoeff N, Herrmann N, Chen JJ, Mah L. Functional connectivity between the posterior default mode network and parahippocampal gyrus is disrupted in older adults with subjective cognitive decline and correlates with subjective memory ability. J Alzheimer’s Disease : JAD. 2021;82(1):435–45.PubMedCrossRef
52.
Costa DSJ, Fardell JE. Why are objective and perceived cognitive function weakly correlated in patients with cancer? J Clin Oncol. 2019;37(14):1154–8.PubMedCrossRef
53.
Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26(1):102–13.PubMedPubMedCentralCrossRef
Metadaten
Titel
Subjective cancer-related cognitive impairments and salience network connectivity in breast cancer survivors
verfasst von
Ashley M. Henneghan
Shelli R. Kesler
Publikationsdatum
05.12.2022
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 4/2023
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-022-01307-8

Weitere Artikel der Ausgabe 4/2023

Journal of Cancer Survivorship 4/2023 Zur Ausgabe

OriginalPaper

Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial

Review

Social adjustment across the lifespan in survivors of pediatric acute lymphoblastic leukemia (ALL): a systematic review

OriginalPaper

Marijuana use among US adults with cancer: findings from the 2018–2019 Behavioral Risk Factor Surveillance System

Review

The unmet supportive care needs of people affected by cancer during the COVID-19 pandemic: an integrative review

OriginalPaper

Breast cancer-related apps in Google Play and App store: evaluate their functionality and quality

OriginalPaper

Medical cannabis-related stigma: cancer survivors’ perspectives

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise